MEDIFAST (MED)
(Delayed Data from NYSE)
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 4:42 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 4:42 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
Zacks News
Medifast (MED) Troubled by High SG&A Costs, Gross Margin Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses for a while now, mainly due to higher OPTAVIA commission costs. The company's gross margin has also been under pressure.
Sprouts Farmers (SFM) Q4 Earnings Beat, Sales Decline Y/Y
by Zacks Equity Research
Sprouts Farmers' (SFM) fourth-quarter 2021 comparable store sales decline 1.1% year over year. For 2022, management forecast comparable store sales growth to be 0-2%.
Keurig Dr Pepper (KDP) Q4 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q4 results gain from solid consumer demand and improvement in the away-from-home channel. Management issues an upbeat 2022 view.
Beyond Meat (BYND) Q4 Loss Wider Than Expected, Stock Down
by Zacks Equity Research
Beyond Meat's (BYND) fourth-quarter 2021 results reflect lower sales and a wider loss compared with the year-ago period. Soft U.S. retail demand due to the pandemic is a downside.
Medifast (MED) Q4 Earnings Beat, Strength in OPTAVIA Key Driver
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Sales and earnings view for 2022 reflect year-over-year growth.
Medifast (MED) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mondelez (MDLZ) Outlines Growth Strategy for AMEA Region
by Zacks Equity Research
Mondelez International (MDLZ) outlines its strategy for the Asia Pacific, Middle East & Africa region at the CAGNY Conference. It has core strategies designed to fuel sustainable growth there.
Molson Coors (TAP) Q4 Earnings Miss Estimates on Inflation
by Zacks Equity Research
Molson Coors' (TAP) Q4 results reflect continued progress on its revitalization plan and premiumization efforts. However, inflationary pressure and supply-chain woes remain concerning.
Are These Consumer Staples Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Top-Ranked Picks Using DuPont Analysis
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on stocks such as Pool Corp. (POOL), MEDIFAST (MED), Builders FirstSource (BLDR), Skyline (SKY) and Robert Half International (RHI).
Medifast (MED) Queued for Q4 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2021 results are likely to reflect strength in the OPTAVIA lifestyle solution and coaching support system and the benefits from growth-related initiatives.
Service Corporation (SCI) Rewards Investors With Dividend Hike
by Zacks Equity Research
Service Corporation (SCI) rewards shareholders by raising the quarterly dividend. Strength in the Cemetery segment is an upside for the company.
McCormick (MKC) Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
McCormick (MKC) is on track to capitalize on the sustained shift to cooking more at home, higher digital engagement, clean and flavorful eating as well as trusted brands.
Mondelez (MDLZ) Gains on Buyouts, Emerging Market Strength
by Zacks Equity Research
Mondelez International (MDLZ) has been benefiting from strategic buyouts as well as the strength in emerging markets. Pricing efforts are also helping the company amid rising cost inflation.
Kraft Heinz (KHC) Q4 Earnings Top Estimates: Pricing a Driver
by Zacks Equity Research
The Kraft Heinz Company's (KHC) robust fourth-quarter 2021 results reflect higher earnings and sales. Efficiency gains and pricing help the company fight inflationary pressure.
TreeHouse (THS) Q4 Earnings Beat on Strong Demand & Pricing
by Zacks Equity Research
TreeHouse's (THS) Q4 results gain from strong demand across categories and robust price realization, as it continues to implement pricing actions to recover from the inflation across the supply chain.
Land on 5 Winning Stocks With the Overlooked Rising P/E Trick
by Sanghamitra Saha
Stocks with rising P/E often proves to be an intriguing investing idea.
Service Corporation's (SCI) Q4 Earnings Top Estimates, View Up
by Zacks Equity Research
Service Corporation's (SCI) fourth-quarter 2021 earnings and sales gain on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
High Demand & Nutrition Unit to Aid Archer Daniels (ADM)
by Zacks Equity Research
Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including portfolio expansion and strategic partnerships.
Flowers Foods (FLO) Q4 Earnings Miss Estimates, Costs Rise
by Zacks Equity Research
Flowers Foods (FLO) fourth-quarter fiscal 2021 results reflect a decline in the top and bottom lines. Although the operating landscape remains tough, early fiscal 2022 results raise optimism.
Conagra (CAG) Gains on Pricing Initiatives Amid Cost Woes
by Zacks Equity Research
Conagra Brands (CAG) has been benefiting from its pricing initiatives along with the recovery of its foodservice business. These have been aiding the company amid rising costs.
Pilgrim's Pride (PPC) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) fourth-quarter sales and earnings increase year over year on strength across all its regions. Cost inflation and labor shortages are a concern.
Coca-Cola (KO) Stock Rises on Q4 Earnings & Revenue Beat
by Zacks Equity Research
Coca-Cola's (KO) Q4 results reflect gains from recovery across markets and strategic transformation. KO also issues an encouraging 2022 view.
Philip Morris (PM) Q4 Earnings Top: Pricing Acts As a Driver
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2021 results reflect increased earnings and revenues, with favorable pricing variance being an upside.
Kellogg's (K) Q4 Earnings & Revenues Top Estimates, Down Y/Y
by Zacks Equity Research
Kellogg's (K) fourth-quarter 2021 results reflect lower earnings and sales. Escalated cost-inflation and shortages are a concern for the company.